Status:

COMPLETED

Human Atherosclerotic Plaque Inflammation Imaged Using PDG-PET/CT

Lead Sponsor:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Conditions:

Insulin Resistance

Atherosclerosis

Eligibility:

All Genders

35-60 years

Brief Summary

People with diabetes are at increased risk for atherosclerosis and have high CVD morbidity and mortality rates. Tools for detecting and quantifying atherosclerotic pro/regression in people with diabet...

Eligibility Criteria

Inclusion

  • Inclusion Criteria for HIV+ group:
  • confirmed HIV+ status
  • 35-60 years old
  • stable ART for at least the past 4 mos
  • CD4 count \>200 cells/µL
  • HIV RNA \<40copies/mL
  • fasting glucose=100-126 mg/dL
  • 2hr-oGTT glucose=140-200mg/dL
  • fasting triglycerides \>150mg/dL
  • HDL-cholesterol \<40mg/dL (men), \<50mg/dL (women)
  • resting blood pressure\>130/85mmHg
  • waist circumference \>102cm(men), \>88cm(women)
  • BMI 25-35 kg/m2
  • For HIV-negative control group:
  • Confirmed HIV negative status
  • 35-60 years old
  • fasting glucose\<100mg/dL,
  • 2hr-oGTT glucose\<140mg/dL
  • fasting triglycerides\<150mg/dL
  • HDL-cholesterol \>40mg/dL (men), \>50mg/dL(women)
  • normal BP (\<130/85mmHg)
  • no central adiposity (waist circ.\<102cm(men), \<88cm(women)
  • BMI (25-35 kg/m2)
  • Exclusion Criteria for both groups:
  • history of heart disease, MI, stroke, transient ischemic attack, kidney or liver disease (active hepatitis B or C), dementia
  • statins, fibrates, TZDs, antihypertensives, low dose aspirin, or other prescribed/over-the-counter agents with anti-inflammatory properties
  • cocaine and methamphetamine users
  • serum creatinine \>1.5 mg/dL
  • pregnant women
  • cognitive impairment that limits ability to provide voluntary informed consent

Exclusion

    Key Trial Info

    Start Date :

    March 1 2009

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    March 1 2010

    Estimated Enrollment :

    14 Patients enrolled

    Trial Details

    Trial ID

    NCT00958815

    Start Date

    March 1 2009

    End Date

    March 1 2010

    Last Update

    June 26 2012

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Washington University School of Medicine

    St Louis, Missouri, United States, 63110